Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 301–400 of 911
Casillas, M. A., Brotherton, S. L., Andrews, L. G., Ruppert, J. M., & Tollefsbol, T. O. (2003) · Gene · doi:10.1016/s0378-1119(03)00739-x · Cited by 51
Huang, F., Chang, C., Wang, J., Chang, T., & Lin, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01997.x · Cited by 49
Zaman, W. S. W. K., Makpol, S., Sathapan, S., & Chua, K. H. (2011) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.38 · Cited by 54
Regulation of telomerase activity by the p53 family member p73
Beitzinger, M., Oswald, C., Beinoravičiūtė-Kellner, R., & Stiewe, T. (2005) · Oncogene · doi:10.1038/sj.onc.1209125 · Cited by 57
Grandjenette, C., Schnekenburger, M., Karius, T., Ghelfi, J., Gaigneaux, A., Henry, E., Dicato, M., & Diederich, M. (2014) · Neoplasia · doi:10.1016/j.neo.2014.05.009 · Cited by 49
Pathways of oncogene-induced senescence in human melanocytic cells
Bansal, R., & Nikiforov, M. A. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12251 · Cited by 53
Trophoblast Invasion and Placentation: Molecular Mechanisms and Regulation
van den Brûle, F., Berndt, S., Simon, N., Coulon, C., Goarant, J. L., Munaut, C., Noël, A., Frankenne, F., & Foidart, J. (2005) · KARGER eBooks · doi:10.1159/000087833 · Cited by 49
Structural insights into the human NuA4/TIP60 acetyltransferase and chromatin remodeling complex
Yang, Z., Mameri, A., Cattoglio, C., Lachance, C., Ariza, A. J. F., Luo, J., Humbert, J., Sudarshan, D., Banerjea, A., Galloy, M., et al. (2024) · Science · doi:10.1126/science.adl5816 · Cited by 50
von Bueren, A. O., Shalaby, T., Oehler‐Jänne, C., Abela, L., Stearns, D. S., Eberhart, C. G., Arcaro, A., Pruschy, M. N., & Grotzer, M. A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-10 · Cited by 49
Zhang, Y., Dakic, A., Chen, R., Dai, Y., Schlegel, R., & Liu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22036 · Cited by 48
Sichero, L. C., Sobrinho, J. S., & Villa, L. L. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis430 · Cited by 48
Yang, J., Deng, X., Deng, L., Gu, H., Fan, W., & Cao, Y. (2004) · PubMed · Cited by 48
The MYC dualism in growth and death
Fuhrmann, G., Rosenberger, G., Grusch, M., Klein, N., Hofmann, J. F.-X., & Krupitza, G. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00084-8 · Cited by 48
Wu, K., Mattioli, M., Morse, H. C., & Dalla‐Favera, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205986 · Cited by 49
Self-citationZhao, Q. J., Yang, Y., Yu, J., You, Q., Zeng, S., Gu, H.-Y., Lu, N., Qi, Q., Liu, W., Wang, X., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.002 · Cited by 48
Soohoo, C., Shi, R., Lee, T. H., Huang, P., Lu, K. P., & Zhou, X. Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180174 · Cited by 56
Papathomas, T. G., Oudijk, L., Zwarthoff, E. C., Post, E., Duijkers, F. A. M., van Noesel, M. M., Hofland, L. J., Pollard, P. J., Maher, E. R., Restuccia, D. F., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0429 · Cited by 49
Ma, L., Lu, H., Chen, R., Wu, M., Jin, Y., Zhang, J., & Wang, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590660 · Cited by 55
Constructing immortalized human cell lines
Yeager, T. R., & Reddel, R. R. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00011-7 · Cited by 55
Hoenerhoff, M. J., Pandiri, A. R., Lahousse, S. A., Hong, H.-H., Ton, T.-V., Masinde, T., Auerbach, S. S., Gerrish, K., Bushel, P. R., Shockley, K. R., et al. (2011) · Toxicologic Pathology · doi:10.1177/0192623311407213 · Cited by 50
Teichroeb, J. H., Kim, J., & Betts, D. H. (2016) · RNA Biology · doi:10.1080/15476286.2015.1134413 · Cited by 46
The hTERT Gene Is Embedded in a Nuclease-resistant Chromatin Domain
Wang, S., & Zhu, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411352200 · Cited by 51
Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFβ
Hu, B., Tack, D. C., Liu, T., Wu, Z., Ullenbruch, M. R., & Phan, S. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209140 · Cited by 49
Kitagawa, Y., Kyo, S., Takakura, M., Kanaya, T., Koshida, K., Namiki, M., & Inoue, M. (2000) · PubMed · Cited by 53
G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
Romano, F., Porzio, A. D., Iaccarino, N., Riccardi, G., Lorenzo, R. D., Laneri, S., Pagano, B., Amato, J., & Randazzo, A. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2271168 · Cited by 47
Human Specific Regulation of the Telomerase Reverse Transcriptase Gene
Zhang, F., Cheng, D., Wang, S., & Zhu, J. (2016) · Genes · doi:10.3390/genes7070030 · Cited by 48
Luo, H. R., Yang, R., Li, C., Tong, Y., Fan, L., Liu, X., & Xu, C. (2017) · Tumor Biology · doi:10.1177/1010428317718414 · Cited by 47
Regulation of Signal Transduction by DJ-1
Oh, S. E., & Mouradian, M. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6583-5_8 · Cited by 49
Alternative splicing is a developmental switch for hTERT expression
Penev, A., Bazley, A., Shen, M. J., Boeke, J. D., Savage, S. A., & Sfeir, A. J. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.033 · Cited by 47
Suvilesh, K. N., Nussbaum, Y. I., Radhakrishnan, V., Manjunath, Y., Avella, D. M., Staveley-O’Carroll, K. F., Kimchi, E. T., Chaudhuri, A. A., Shyu, C., Li, G., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01553-5 · Cited by 45
A major role of PKC θ and NFκB in the regulation of hTERT in human T lymphocytes
Sheng, W.-Y., Chen, Y.-R., & Wang, T.-C. V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.044 · Cited by 41
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines
Pizzimenti, S., Briatore, F., Laurora, S., Toaldo, C., Maggio, M., Grandi, M. D., Meaglia, L., Menegatti, E., Giglioni, B., Dianzani, M. U., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.024 · Cited by 47
Takeda, T., Inaba, H., Yamazaki, M., Kyo, S., Miyamoto, T., Suzuki, S., Ehara, T., Kakizawa, T., Hara, M., DeGroot, L. J., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021856 · Cited by 46
Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor
Nakamura, M., Saito, H., Ebinuma, H., Wakabayashi, K., Saito, Y., Takagi, T., Nakamoto, N., & Ishii, H. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1087 · Cited by 48
Eitsuka, T., Nakagawa, K., Suzuki, T., & Miyazawa, T. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.017 · Cited by 47
Ratsch, S. B., Gao, Q., Srinivasan, S., Wazer, D. E., & Band, V. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0143:mgcarf]2.0.co;2 · Cited by 44
Pallini, R., Pierconti, F., Falchetti, M. L., D’Arcangelo, D., Fernandez, E., Maira, G., D’Ambrosio, E., & Larocca, L. M. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.94.6.0961 · Cited by 46
Budiyanto, A., Bito, T., Kunisada, M., Ashida, M., Ichihashi, M., & Ueda, M. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12529.x · Cited by 45
Mechanisms of Action of TGF‐β in Cancer: Evidence for Smad3 as a Repressor of the hTERT Gene
Li, H., & Liu, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.016 · Cited by 47
Franzese, O., Adamo, R., Pollicita, M., Comandini, A., Laudisi, A., Perno, C. F., Aquaro, S., & Bonmassar, E. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20855 · Cited by 47
Cassar, L., Nicholls, C., Pinto, A. R., Chen, R., Wang, L., Li, H., & Liu, J.-P. (2017) · Protein & Cell · doi:10.1007/s13238-016-0322-1 · Cited by 42
Ma, J., Ju, X., Xu, R., Wang, W.-H., Luo, Z., Liu, C., Yang, L., Li, B., Chen, J., Meng, B., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0419-19.2019 · Cited by 45
Shkreli, M., Dambrine, G., Soubieux, D., Kut, E., & Rasschaert, D. (2007) · Journal of Virology · doi:10.1128/jvi.02530-06 · Cited by 47
Molecular marks for epigenetic identification of developmental and cancer stem cells
Patra, S. K., Deb, M., & Patra, A. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0016-0 · Cited by 46
Epigenetic regulation of hTERT promoter in hepatocellular carcinomas
Tsezou (1992) · International Journal of Oncology · doi:10.3892/ijo_00000162 · Cited by 52
Bazarov, A., Adachi, S., Li, S. F., Mateyak, M. K., Wei, S., & Sedivy, J. M. (2001) · PubMed · Cited by 47
Yasui, W., Tahara, E., Tahara, H., Fujimoto, J., Naka, K., Nakayama, J., Ishikawa, F., Ide, T., & 田原, 榮. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00787.x · Cited by 51
TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma
Chun‐on, P., Hinchie, A. M., Beale, H. C., Silva, A. A. G., Rush, E. A., Sander, C., Connelly, C. J., Seynnaeve, B. K. N., Kirkwood, J. M., Vaske, O. M., et al. (2022) · Science · doi:10.1126/science.abq0607 · Cited by 44
The Effectiveness of Cucurbitacin B in BRCA1 Defective Breast Cancer Cells
Promkan, M., Dakeng, S., Chakrabarty, S., Bögler, O., & Patmasiriwat, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055732 · Cited by 43
ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes
Dakic, A., DiVito, K. A., Fang, S., Suprynowicz, F. A., Gaur, A., Li, X., Palechor-Ceron, N., Simić, V., Choudhury, S., Yu, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11458 · Cited by 44
Platella, C., Raucci, U., Rega, N., D’Atri, S., Levati, L., Roviello, G. N., Fuggetta, M. P., Musumeci, D., & Montesarchio, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.160 · Cited by 43
Khathayer, F. H., & Ray, S. K. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03093-0 · Cited by 43
TGF-β and cancer: Is Smad3 a repressor of hTERT gene?
Li, H., Xu, D., Toh, B., & Liu, J. (2006) · Cell Research · doi:10.1038/sj.cr.7310023 · Cited by 43
Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming
Han, J. W., & Yoon, Y. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3814 · Cited by 50
Lundberg, G., Sehic, D., Länsberg, J., Øra, I., Frigyesi, A., Castel, V., Navarro, S., Piqueras, M., Martinsson, T., Noguera, R., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20850 · Cited by 43
Tornesello, M. L., Cerasuolo, A., Starita, N., Amiranda, S., Bonelli, P., Tuccillo, F. M., Buonaguro, F. M., Buonaguro, L., & Tornesello, A. L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1286683 · Cited by 42
Direct regulation of HSP60 expression by c‐MYC induces transformation
Tsai, Y., Teng, S., & Wu, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.11.004 · Cited by 42
Self-citationDinami, R., Buemi, V., Sestito, R., Zappone, A., Ciani, Y., Mano, M., Petti, E., Sacconi, A., Blandino, G., Giacca, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21180 · Cited by 42
Song, J.-S., Kim, H.-P., Yoon, W., Lee, K.-W., Mee-Hye, K. I. M., Kim, K., Kim, H.-S., & Kim, Y. T. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.2344 · Cited by 45
Braunstein, I., Cohen‐Barak, O., Shachaf, C. M., Ravel, Y., Yalon-Hacohen, M., Mills, G. B., Tzukerman, M., & Skorecki, K. L. (2001) · PubMed · Cited by 46
Kraveka, J. M., Li, L., Bielawski, J., Obeid, L. M., & Öğretmen, B. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.034 · Cited by 43
Recent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 43
Villa, R., Porta, C. D., Folini, M., Daidone, M. G., & Zaffaroni, N. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01343.x · Cited by 45
AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation
Jackstadt, R., Jung, P., & Hermeking, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.282 · Cited by 42
Sitaram, R. T., Degerman, S., Ljungberg, B., Andersson, E., Oji, Y., Sugiyama, H., Roos, G., & Li, A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605878 · Cited by 41
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex
He, Z., Deng, F. M., Wei, X., Ma, C., Luo, M., Zhang, P., Sang, Y., Liang, X., Liu, L., Qin, H., et al. (2016) · Scientific Reports · doi:10.1038/srep23764 · Cited by 41
Gojo, J., Lötsch, D., Spiegl‐Kreinecker, S., Pajtler, K. W., Neumayer, K., Korbel, P., Araki, A., Brandstetter, A., Mohr, T. T., Hovestadt, V., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox027 · Cited by 42
Lavanya, C., Venkataswamy, M. M., Sibin, M. K., Bharath, M. M. S., & Chetan, G. K. (2018) · Cytotechnology · doi:10.1007/s10616-018-0205-9 · Cited by 42
Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review
Eitsuka, T., Nakagawa, K., Kato, S., Ito, J., Otoki, Y., Takasu, S., Shimizu, N., Takahashi, T., & Miyazawa, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020478 · Cited by 42
Zhang, H., Weng, X., Ye, J., He, L., Zhou, D., & Liu, Y. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.01.002 · Cited by 42
Biroccio, A., Amodei, S., Antonelli, A., Benassi, B., & Zupi, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304597200 · Cited by 42
Suzuki, T., Yokozaki, H., Kuniyasu, H., Hayashi, K., Naka, K., Ono, S., Ishikawa, T., Tahara, E., & Yasui, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001215)88:6<992::aid-ijc24>3.0.co;2-9 · Cited by 121
Tzukerman, M., Shachaf, C., Ravel, Y., Braunstein, I., Cohen-Barak, O., Yalon-Hacohen, M., & Skorecki, K. L. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4381 · Cited by 42
RETRACTED: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced autophagy in a bovine kidney cell line
Fiorito, F., Ciarcia, R., Granato, G. E., Marfè, G., Iovane, V., Florio, S., Martino, L. D., & Pagnini, U. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.004 · Cited by 40
RetractedRahman, R., Osteso-Ibáñez, T., Hirst, R. A., Levesley, J., Kilday, J., Quinn, S., Peet, A. C., O’Callaghan, C., Coyle, B., & Grundy, R. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0272 · Cited by 40
Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer
Adjiri, A. (2016) · Oncology and Therapy · doi:10.1007/s40487-015-0015-6 · Cited by 45
Takasawa, K., Arai, Y., Yamazaki‐Inoue, M., Toyoda, M., Akutsu, H., Umezawa, A., & Nishino, K. (2017) · Human Cell · doi:10.1007/s13577-017-0190-x · Cited by 52
Behrooz, A. B., & Syahir, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.642719 · Cited by 45
Zhu, C.-Y., Li, C.-Y., Li, Y., Zhan, Y.-Q., Yh, L., Cw, X., Xu, W.-X., Sun, H., & Yang, X.-M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.160 · Cited by 40
Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells.
Matte, M. Y. A.-D., Yang, H., Evans, M. S., Cheng, J. Q., & Kruk, P. A. (2002) · PubMed · Cited by 40
Rama, S., Suresh, Y., & Rao, A. J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00202-8 · Cited by 40
Telomerase and c-myc expression in hepatocellular carcinomas
Liu, Y., Chen, C., Wu, H., Chan, D., Yu, J.-C., Yang, A., Cheng, Y.-L., Lee, S.-C., & Harn, H. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.01.003 · Cited by 41
Hu, B. T., & Insel, R. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3745::aid-immu3745>3.0.co;2-1 · Cited by 42
Telomerase inhibitors: targeting the vulnerable end of cancer?
Kèlland, L. R. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00001 · Cited by 43
Cottage, C. T., Neidig, L., Sundararaman, B., Din, S., Joyo, A. Y., Bailey, B., Gude, N., Hariharan, N., & Sussman, M. A. (2012) · STEM CELLS · doi:10.1002/stem.1211 · Cited by 40
ZEB1 stimulates breast cancer growth by up-regulating hTERT expression
Pan, Y., Shen, X. H., Yang, W., Zhang, Y., Liu, C., & Huang, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.139 · Cited by 41
Targeting DNA binding proteins for cancer therapy
Shiroma, Y., Takahashi, R., Yamamoto, Y., & Tahara, H. (2020) · Cancer Science · doi:10.1111/cas.14355 · Cited by 41
RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells
Lagah, S., Tan, I., Radhakrishnan, P., Hirst, R. A., Ward, J. H., O’Callaghan, C., Smith, S. J., Stevens, M. F. G., Grundy, R. G., & Rahman, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086187 · Cited by 39
Tentori, L., Balduzzi, A., Portarena, I., Levati, L., Vernole, P., Gold, B. I., Bonmassar, E., & Graziani, G. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400863 · Cited by 45
Azouz, A., Wu, Y.-L., Hillion, J., Tárkányi, I., Karniguian, A., Aradi, J., Lanotte, M., Chen, G.-Q., Chehna, M. F., & Ségal-Bendirdjian, E. (2010) · Leukemia · doi:10.1038/leu.2009.283 · Cited by 42
Telomerase, Telomerase Inhibition, and Cancer
Ahmed, A., & Tollefsbol, T. O. (2003) · Rejuvenation Research · doi:10.1089/109454503323028911 · Cited by 43
Role of Ets/Id proteins for telomerase regulation in human cancer cells
Xiao, X., Athanasiou, M., Sidorov, I. A., Horikawa, I., Cremona, G. H., Blair, D. G., Barret, J., & Dimitrov, D. S. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00092-3 · Cited by 40
Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for Cancer
Ahmed, A., & Tollefsbol, T. O. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51019.x · Cited by 41
Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 44
Self-citationDastmalchi, N., Safaralizadeh, R., Baradaran, B., Hosseinpourfeizi, M., & Baghbanzadeh, A. (2019) · Gene · doi:10.1016/j.gene.2019.144301 · Cited by 38
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
Meriranta, L., Pasanen, A., Alkodsi, A., Haukka, J. K., Karjalainen‐Lindsberg, M., & Leppä, S. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001727 · Cited by 41
Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder
Lundberg, M., Millischer, V., Backlund, L., Martinsson, L., Stenvinkel, P., Sellgren, C. M., Lavebratt, C., & Schalling, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.586083 · Cited by 41
Telomere length regulation during cloning, embryogenesis and ageing
Schaetzlein, S., & Rudolph, K. L. (2004) · Reproduction Fertility and Development · doi:10.1071/rd04112 · Cited by 43
Moon, D., Kim, M.-O., Heo, M., Lee, J.-D., Choi, Y. H., & Kim, G. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-2002-7 · Cited by 39
Zhao, L., & Wink, M. (2013) · PeerJ · doi:10.7717/peerj.174 · Cited by 43
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.